ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,908Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 2456

$1.79M Total Retail Price of All Prescriptions

Rank: 9 out of 2456

698 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 698 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 698 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 30,433 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,992 1,955 1 9
FUROSEMIDE 1,433 1,397 2 8
TRAZODONE HCL 1,353 1,245 3 17
LEVOTHYROXINE SODIUM 1,300 1,233 4 4
LISINOPRIL 986 929 5 1
CITALOPRAM HBR 983 935 6 14
DONEPEZIL HCL 847 834 7 23
METOPROLOL TARTRATE 842 781 8 10
SIMVASTATIN 807 745 9 2
MIRTAZAPINE 730 709 10 29
ATENOLOL 623 604 11 6
AMLODIPINE BESYLATE 585 581 12 5
NAMENDA 559 543 13 42
OMEPRAZOLE 543 509 14 3
POTASSIUM CHLORIDE 523 497 15 33
SERTRALINE HCL 468 427 16 21
PREDNISONE 386 364 17 39
RISPERIDONE 370 331 18 50
ISOSORBIDE MONONITRATE ER 362 361 19 48
OLANZAPINE 355 307 20 57
GABAPENTIN 353 316 21 16
METOPROLOL SUCCINATE 331 327 22 13
FLUOXETINE HCL 328 261 23 45
CYMBALTA 324 299 24 65
FENTANYL 279 258 S2 25 115
ATORVASTATIN CALCIUM 272 249 26 12
ADVAIR DISKUS 253 241 27 36
METFORMIN HCL 253 221 27 11
DIVALPROEX SODIUM 247 201 29 51
SPIRIVA 247 217 29 43
QUETIAPINE FUMARATE 234 216 31 47
DIGOXIN 232 213 32 49
TRAMADOL HCL 221 211 33 24
TAMSULOSIN HCL 210 187 34 32
CARBIDOPA-LEVODOPA 203 196 35 82
POLYETHYLENE GLYCOL 3350 193 181 36 64
HYDROCODONE-ACETAMINOPHEN 191 170 S3 37 20
PANTOPRAZOLE SODIUM 183 161 38 37
DILTIAZEM 24HR CD 180 175 39 113
ALLOPURINOL 177 177 40 27
LANTUS 175 175 41 44
PAROXETINE HCL 175 165 41 56
LIDODERM 173 146 43 58
OXYBUTYNIN CHLORIDE ER 165 137 44 94
NYSTOP 163 160 45 125
HYDROCHLOROTHIAZIDE 160 146 46 7
IPRATROPIUM-ALBUTEROL 150 142 47 85
LOSARTAN POTASSIUM 142 140 48 18
CLOPIDOGREL 142 137 48 55
DIOVAN 140 140 50 26
AZITHROMYCIN 139 126 51 60
NOVOLIN N 131 118 52 202
CIPROFLOXACIN HCL 127 116 53 87
SPIRONOLACTONE 127 127 53 73
ALENDRONATE SODIUM 126 123 55 19
ESCITALOPRAM OXALATE 125 120 56 116
NYSTATIN 119 117 57 99
EXELON 118 115 58 161
LEVOFLOXACIN 117 111 59 103
GLIPIZIDE 115 103 60 46
LEVETIRACETAM 114 103 61 90
OXYCODONE HCL 113 91 S2 62 38
MELOXICAM 112 93 63 121
FLUTICASONE PROPIONATE 106 95 64 30
ABILIFY 101 86 65 95
OXCARBAZEPINE 98 70 66 190
IBUPROFEN 97 69 67 52
KLOR-CON M20 95 77 68 69
CEPHALEXIN 91 82 69 153
BUSPIRONE HCL 86 86 70 157
PHENYTOIN SODIUM EXTENDED 84 84 71 140
FINASTERIDE 84 84 71 66
ALBUTEROL SULFATE 83 75 73 165
PLAVIX 82 78 74 79
ZOLPIDEM TARTRATE 81 67 75 28
SINGULAIR 81 69 75 149
ROPINIROLE HCL 79 79 77 148
METOCLOPRAMIDE HCL 79 67 77 170
NOVOLOG 78 68 79 100
NITROFURANTOIN MONO-MACRO 77 76 80 231
VENLAFAXINE HCL ER 75 75 81 92
GLYBURIDE 73 73 R 82 40
DILTIAZEM HCL 71 71 83 207
CRESTOR 71 38 83 25
PRAVASTATIN SODIUM 70 70 85 15
RANITIDINE HCL 69 66 86 31
OXYCODONE-ACETAMINOPHEN 69 47 S2 86 35
HYDRALAZINE HCL 68 68 88 105
FLUDROCORTISONE ACETATE 67 44 89 260
CELEBREX 67 66 89 127
DETROL LA 67 58 89 228
PROPRANOLOL HCL 66 64 92 108
CARBAMAZEPINE 66 55 92 155
CLOTRIMAZOLE-BETAMETHASONE 66 62 92 182
BUPROPION HCL SR 66 55 92 119
ARANESP 65 65 96 440
LATANOPROST 64 64 97 156
BRIMONIDINE TARTRATE 64 64 97 249
METHIMAZOLE 63 63 99 248
JANUVIA 63 53 99 81
CLOBETASOL PROPIONATE 63 52 99 208
SEROQUEL 63 58 99 102
AMIODARONE HCL 63 63 99 203
ERYTHROMYCIN 62 62 104 241
FENOFIBRATE 61 61 105 68
VERAPAMIL ER 61 53 105 91
GENERLAC 61 52 105 142
LOVASTATIN 60 47 108 34
NEXIUM 60 56 108 80
METHOTREXATE 60 60 108 159
VENLAFAXINE HCL 60 49 108 188
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 52 108 147
MIDODRINE HCL 58 45 113 456
CARVEDILOL 56 53 114 54
BACLOFEN 54 48 115 112
MORPHINE SULFATE 53 53 S2 116 226
CLONIDINE HCL 52 37 117 111
TRAVATAN Z 52 52 117 290
BETAMETHASONE DIPROPIONATE 51 46 119 233
NIFEDIPINE ER 50 50 120 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.